Sales and Marketing

Showing 15 posts of 11524 posts found.

cancer-vs-alzheimer-1080x810

Cancer Research UK partners with Biotecnol to deliver experimental solid tumour drug

August 10, 2017 Research and Development, Sales and Marketing Biotecnol, Cancer, Cancer Research UK, drugs, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …
rasmus-web

Alvotech recruit new CEO from within

August 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alvotech, biotech, drugs, pharma, pharmaceutical

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …
shutterstock_38078521

FDA awards orphan status to new brain cancer vaccine

August 9, 2017 Research and Development, Sales and Marketing FDA, life sciences, orphan drug, pharma, pharmaceuticals

The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the …
valeant

Valeant focused on bringing new products to market, receives CRL

August 9, 2017 Research and Development, Sales and Marketing Valeant, biotech, drugs, pharma, pharmaceutical

In its second quarter financial reports, Valeant strove to strike a positive note. It revealed that it had paid down …

Takeda reveals collaboration aimed at bolstering oncology pipeline

August 8, 2017 Manufacturing and Production, Sales and Marketing Molecular Templates, Takeda, biotech, drugs, oncology, pharma, pharmaceutical

It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …

Merck scores expanded NICE recommendation in head, neck and oral cancer

August 8, 2017 Manufacturing and Production, Sales and Marketing Erbitux, Merck, NICE, biotech, cetuximah, drugs, life sciences, pharma, pharmaceuticals

Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …
nice_new_london_office_internal_3_web

NICE recommends plaque psoriasis contender for NHS use

August 8, 2017 Manufacturing and Production, Sales and Marketing Almirall, NICE< Skilarence, drugs, life sciences, medicine, pharma, pharmaceuticals, plaque psoriasis, psoriasis

The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …
juan_andres

Moderna appoint Novartis vet to scale-up manufacturing

August 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moderna, Novartis, biotech, drugs, pharma, pharmaceutical

Moderna Therapeutics, a clinical stage biotechnology company, has appointed Juan Andres to the position of Senior Vice President of Late …

Bayer secures one-two treatment for liver cancer after EU approval

August 7, 2017 Sales and Marketing Bayer, biotech, drugs, pharma, pharmaceutical

Bayer has announced that it has received European Commission approval for its treatment of hepatocellular carcinoma, a type of liver …
shutterstock_311949818

Stomach acid drugs do not increase Alzheimer’s risk, study confirms

August 7, 2017 Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

HIV-preventing drug to be trialed across England

August 7, 2017 Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical

NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …
fda_building_web

Vernalis cough and cold drug knocked-back by FDA

August 7, 2017 Sales and Marketing Vernalis, biotech, drugs, pharma, pharmaceutical, tris pharma

Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, …
fda2outsideweb

FDA fast tracks Valneva’s Lyme disease vaccine

August 7, 2017 Research and Development, Sales and Marketing Valneva, biotech, life sciences, lyme disease, medicines, pharma, pharmaceutcial

French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …
The Gateway to Local Adoption Series

Latest content